-
Signature
-
/s/ Kevin Kane as Attorney-in-Fact for Marc Fredman
-
Issuer symbol
-
CCCS
-
Transactions as of
-
14 Mar 2024
-
Transactions value $
-
-$8,223,627
-
Form type
-
4
-
Filing time
-
18 Mar 2024, 17:51:24 UTC
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
CCCS |
Common Stock |
Options Exercise |
$389,347 |
+155,739 |
+67.72% |
$2.5 |
385,697 |
14 Mar 2024 |
Direct |
F1 |
| transaction |
CCCS |
Common Stock |
Options Exercise |
$379,492 |
+151,797 |
+39.36% |
$2.5 |
537,494 |
14 Mar 2024 |
Direct |
F1 |
| transaction |
CCCS |
Common Stock |
Sale |
-$3,948,751 |
-324,952 |
-60.46% |
$12.15 |
212,542 |
14 Mar 2024 |
Direct |
F1, F2 |
| transaction |
CCCS |
Common Stock |
Options Exercise |
$374,602 |
+149,841 |
+70.5% |
$2.5 |
362,383 |
15 Mar 2024 |
Direct |
F1 |
| transaction |
CCCS |
Common Stock |
Options Exercise |
$377,632 |
+151,053 |
+41.68% |
$2.5 |
513,436 |
15 Mar 2024 |
Direct |
F1 |
| transaction |
CCCS |
Common Stock |
Sale |
-$3,554,731 |
-300,894 |
-58.6% |
$11.81 |
212,542 |
15 Mar 2024 |
Direct |
F1, F3 |
| transaction |
CCCS |
Common Stock |
Options Exercise |
$296,885 |
+118,754 |
+35.58% |
$2.5 |
452,532 |
18 Mar 2024 |
Direct |
F1 |
| transaction |
CCCS |
Common Stock |
Options Exercise |
$303,090 |
+121,236 |
+57.04% |
$2.5 |
333,778 |
18 Mar 2024 |
Direct |
F1 |
| transaction |
CCCS |
Common Stock |
Sale |
-$2,841,193 |
-239,990 |
-53.03% |
$11.84 |
212,542 |
18 Mar 2024 |
Direct |
F1, F4 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
CCCS |
Stock Option (Right to Buy) |
Options Exercise |
$0 |
-155,739 |
-30.49% |
$0 |
355,087 |
14 Mar 2024 |
Common Stock |
155,739 |
$2.5 |
Direct |
F1, F5 |
| transaction |
CCCS |
Stock Option (Right to Buy) |
Options Exercise |
$0 |
-151,797 |
-29.72% |
$0 |
359,029 |
14 Mar 2024 |
Common Stock |
151,797 |
$2.5 |
Direct |
F1, F6 |
| transaction |
CCCS |
Stock Option (Right to Buy) |
Options Exercise |
$0 |
-149,841 |
-42.2% |
$0 |
205,246 |
15 Mar 2024 |
Common Stock |
149,841 |
$2.5 |
Direct |
F1, F5 |
| transaction |
CCCS |
Stock Option (Right to Buy) |
Options Exercise |
$0 |
-151,053 |
-42.07% |
$0 |
207,976 |
15 Mar 2024 |
Common Stock |
151,053 |
$2.5 |
Direct |
F1, F6 |
| transaction |
CCCS |
Stock Option (Right to Buy) |
Options Exercise |
$0 |
-118,754 |
-57.86% |
$0 |
86,492 |
18 Mar 2024 |
Common Stock |
118,754 |
$2.5 |
Direct |
F1, F5 |
| transaction |
CCCS |
Stock Option (Right to Buy) |
Options Exercise |
$0 |
-121,236 |
-58.29% |
$0 |
86,740 |
18 Mar 2024 |
Common Stock |
121,236 |
$2.5 |
Direct |
F1, F6 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: